NATLEEPROJECTSTalk confidentiallyContact

Pharma & biotech · Technology and supplier decisions

De-risk technical and commercial decisions in quality-sensitive growth.

For industrial technology, supplier selection and value-chain change where evidence, traceable decisions and cross-functional implementation matter.

At risk: technical suitability · award quality · implementation pace · supply resilience

Describe the situation

Typical pressure points

When the operating system stops aligning.

  • A new technology requires a robust technical and commercial partner decision.
  • Risk, opportunity, quality and cost criteria are evaluated in separate workstreams.
  • Growth exposes gaps between procurement, suppliers, operations and ERP data.
  • A transformation needs stronger ownership without overstating specialist regulatory scope.

Where the mandate can start

Connect business risk to executable ownership.

01

Structured sourcing

Build a transparent tender and evaluation process around technical fit, quality, figures, risks and opportunities.

Structured sourcing
02

Project decision system

Clarify facts, dependencies, owners and escalation logic before commitments become costly to reverse.

Project decision system
03

Implementation ownership

Coordinate cross-functional execution and management decisions through a defined transformation phase.

Implementation ownership

Initial control questions

Establish the decision base before adding activity.

  1. 01Which technical and commercial assumptions still lack a shared evidence base?
  2. 02Which supplier or technology risk could become expensive after award?
  3. 03Which interface needs one accountable decision owner now?

Relevant experience

Comparable project contexts.

A documented biotech / FMCG mandate covered risk and opportunity management, tendering and partner selection for new turnkey technology.

2023–2024 · Biotech / FMCG · Germany · Company with approx. €25m revenue

Supplier selection for new turnkey technology

Situation: A new technology required a robust technical and commercial award decision.

Mandate / intervention: Risk and opportunity management, a structured tender process, and partner selection based on quality, figures and technical suitability.

View full track record

Other operating environments

The same pressure can cross industry boundaries.

Direct and confidential

Which business risk must be brought under control?

The selected industry and mandate context are carried into the enquiry. Add only the situation, risk and required outcome.

Describe the situation